Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
| Status: | Completed |
|---|---|
| Conditions: | Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 10/11/2017 |
| Start Date: | March 2014 |
| End Date: | May 2016 |
This is a clinical study comparing targeted levothyroxine dosing based on thyroid anatomy as
visualized on ultrasound (normal vs. ectopic/sublingual vs. athyreosis) to empiric
levothyroxine dosing in infants with congenital hypothyroidism. Patients enrolled in the
study for targeted dosing will be compared to controls obtained by retrospective chart
review. The main outcome is to determine if there is a difference in the frequency of
over-treatment and under-treatment during the first 6 months of therapy.
visualized on ultrasound (normal vs. ectopic/sublingual vs. athyreosis) to empiric
levothyroxine dosing in infants with congenital hypothyroidism. Patients enrolled in the
study for targeted dosing will be compared to controls obtained by retrospective chart
review. The main outcome is to determine if there is a difference in the frequency of
over-treatment and under-treatment during the first 6 months of therapy.
Inclusion Criteria:
- Newborns diagnosed with congenital hypothyroidism (CH).
- Newborns with CH who are treated by a pediatric endocrinologist at Riley Hospital for
Children or satellite location.
- Newborns with CH who have thyroid imaging performed (thyroid ultrasound or technetium
scan) at diagnosis.
Exclusion Criteria:
- Newborns who do not have CH.
- Newborns with CH who have not had thyroid imaging performed at diagnosis.
We found this trial at
1
site
Riley Hospital for Children Riley Hospital for Children at IU Health is a place of...
Click here to add this to my saved trials
